Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections

Background. Results from the Costa Rica Vaccine Trial (CVT) demonstrated partial cross-protection by the bivalent human papillomavirus (HPV) vaccine, which targets HPV-16 and HPV-18, against HPV-31, -33, and -45 infection and an increased incidence of HPV-51 infection. Methods. A study nested within...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Harari, Ariana, Chen, Zigui, Rodríguez, Ana Cecilia, Hildesheim, Allan, Porras, Carolina, Herrero, Rolando, Wacholder, Sholom, Panagiotou, Orestis A., Befano, Brian, Burk, Robert D., Schiffman, Mark
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760417/
https://ncbi.nlm.nih.gov/pubmed/26518044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv519
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars